ARCHIVES

Univ. of Rochester Leads Trial Of Combination Chemotherapy For Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Recommend Use of Cytokines GM-CSF, G-CSF In BMT And Chemotherapy

January 4, 1991

Patient Advocacy: Survivorship Programs Win Funds To form Model Programs

December 13, 1996

Natcher Subcommittee Open Door To justification for Increasing Cancer Program 1982 Appropriation

April 3, 1981

NCI Asks $135 Billion for FY 1981, Tells How New Money Would Be Spent

June 1, 1979

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

January 25, 2002

Hawkins Calls For Joins Cancer Center-Community Effort To Develop Better Technology Transfers

May 29, 1981